Description

The human immunodeficiency virus (HIV) and the human T-cell lymphotropic virus type 1 (HTLV-1) are examples of RG3 pathogens where the pathogen risk and CL assessments have been revisited by the Agency in conjunction with HIV/HTLV specialists based on current risks associated with activities involving these pathogens. It has been determined that HIV & HTLV-1 can be safely handled at CL2/CL2-Ag with specific additional operational requirements (see Section 4.0). This Biosafety Directive is intended to provide a comprehensive overview of the risk assessment outcomes, subsequent CL decisions, and considerations that have been made for those working with HIV and HTLV-1. The Biosafety Directive for HIV and HTLV-1 is to be used in conjunction with the CBSG.

Resources

Name	Format	Description	Link
Biosafety Directive for Human Immunodeficiency Virus (HIV) and Human T-cell Lymphotropic Virus Type 1 (HTLV-1)	HTML		https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/biosafety-directive-human-immunodeficiency-virus-hiv-human-cell-lymphotropic-virus-type-1-htlv-1.html
Biosafety Directive for Human Immunodeficiency Virus (HIV) and Human T-cell Lymphotropic Virus Type 1 (HTLV-1)	HTML		https://www.canada.ca/fr/sante-publique/services/biosecurite-biosurete-laboratoire/directive-matiere-biosecurite-portant-virus-immunodeficience-humaine-vih-virus-lymphotrope-humain-type-1-htlv-1.html

Tags

Topics

Categories